victoriaantoniou, Author at European Medical Journal - Page 6 of 22

Engineered Heart Muscle Patch Transforms Heart Failure Treatment

Engineered heart muscle allografts safely remuscularize failing hearts, showing promise for heart failure treatment in primates and humans.

Shared Care Model for Hematopoietic Cell Transplantation Shows Promise

Shared care after HCT improves quality of life at day 100 without affecting survival, offering a viable post-transplant model.

New Equation May Improve Early Detection of Diabetic Nephropathy

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area.

New Insights into Predicting Remission for Severe Asthma Using Mepolizumab

Early ACQ-5 score predicts mepolizumab treatment success in severe eosinophilic asthma, guiding clinical decisions.

IPF Gene Variant May Protect Lungs Post-COVID-19

A recent study has uncovered a new connection between genetic risk factors for idiopathic pulmonary fibrosis and the development of post-COVID-19 lung abnormalities.

Improving Quality of Life in BPH Treatment Advances

Recent advancements in ejaculation-preserving techniques during HoLEP have yielded encouraging results.

Fetuses with Congenital Heart Disease Have Impaired Placental Function and Growth

Reduced placental flow and malperfusion defects in fetuses with CHD highlight potential pathways impacting growth and outcomes.

Deep-Learning Model for Lung Tumour Detection and Segmentation

Novel deep-learning model has shown promise in identifying and segmenting lung tumours according to new research.

The Role of Antimicrobials and Vaccines in Reducing Dementia Risk

Data review suggests antibiotics, vaccines, and anti-inflammatory drugs reduce dementia risk, advancing drug repurposing opportunities.

Low Lymphocyte Count Linked to Poorer Survival in Multiple Myeloma

Low lymphocyte count at diagnosis and during treatment is associated with poorer survival in multiple myeloma patients.